Cargando…

Survey on the impact of comorbid allergic rhinitis in patients with asthma

BACKGROUND: Allergic rhinitis (AR) and asthma are inflammatory conditions of the airways that often occur concomitantly. This global survey was undertaken to understand patient perspectives regarding symptoms, treatments, and the impact on their well-being of comorbid AR and asthma. METHODS: Survey...

Descripción completa

Detalles Bibliográficos
Autores principales: Valovirta, Erkka, Pawankar, Ruby
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698496/
https://www.ncbi.nlm.nih.gov/pubmed/17140421
http://dx.doi.org/10.1186/1471-2466-6-S1-S3
_version_ 1782131235762470912
author Valovirta, Erkka
Pawankar, Ruby
author_facet Valovirta, Erkka
Pawankar, Ruby
author_sort Valovirta, Erkka
collection PubMed
description BACKGROUND: Allergic rhinitis (AR) and asthma are inflammatory conditions of the airways that often occur concomitantly. This global survey was undertaken to understand patient perspectives regarding symptoms, treatments, and the impact on their well-being of comorbid AR and asthma. METHODS: Survey participants were adults with asthma (n = 813) and parents of children with asthma (n = 806) from four countries each in the Asia-Pacific region and Europe. Patients included in the survey also had self-reported, concomitant AR symptoms. Patients and parents were recruited by telephone interview or by direct interview. RESULTS: Most patients (73%) had pre-existing symptoms of AR when their asthma was first diagnosed. Shortness of breath (21%) was the most troublesome symptom for adults, and wheezing (17%) and coughing (17%) the most troublesome for children. Patients used different medications for treating asthma (most commonly short-acting β-agonists and inhaled corticosteroids) and for treating AR (most commonly oral antihistamines). The concomitant presence of AR and asthma disrupted the ability to get a good night's sleep (79%), to participate in leisure and sports activities (75%), to concentrate at work or school (69% of adults, 73% of children), and to enjoy social activities (57% of adults, 51% of children). Most patients (79%) reported worsening asthma symptoms when AR symptoms flared up. Many (56%) avoided the outdoors during the allergy season because of worsening asthma symptoms. Many (60%) indicated difficulty in effectively treating both conditions, and 72% were concerned about using excessive medication. In general, respondents from the Asia-Pacific region reported more disruption of activities caused by symptoms and more concerns and difficulties with medications than did those from Europe. Differences between the two regions in medication use included more common use of inhaled corticosteroids in Europe and more common use of Chinese herbal remedies in the Asia-Pacific region. CONCLUSION: Results of this survey suggest that comorbid asthma and AR substantially impact patient well-being and that the worsening of AR symptoms in patients with asthma can be associated with worsening asthma symptoms. These findings underscore the need for physicians who treat patients with asthma to evaluate treatment options for improving symptoms of both AR and asthma when present concomitantly.
format Text
id pubmed-1698496
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-16984962006-12-13 Survey on the impact of comorbid allergic rhinitis in patients with asthma Valovirta, Erkka Pawankar, Ruby BMC Pulm Med Review BACKGROUND: Allergic rhinitis (AR) and asthma are inflammatory conditions of the airways that often occur concomitantly. This global survey was undertaken to understand patient perspectives regarding symptoms, treatments, and the impact on their well-being of comorbid AR and asthma. METHODS: Survey participants were adults with asthma (n = 813) and parents of children with asthma (n = 806) from four countries each in the Asia-Pacific region and Europe. Patients included in the survey also had self-reported, concomitant AR symptoms. Patients and parents were recruited by telephone interview or by direct interview. RESULTS: Most patients (73%) had pre-existing symptoms of AR when their asthma was first diagnosed. Shortness of breath (21%) was the most troublesome symptom for adults, and wheezing (17%) and coughing (17%) the most troublesome for children. Patients used different medications for treating asthma (most commonly short-acting β-agonists and inhaled corticosteroids) and for treating AR (most commonly oral antihistamines). The concomitant presence of AR and asthma disrupted the ability to get a good night's sleep (79%), to participate in leisure and sports activities (75%), to concentrate at work or school (69% of adults, 73% of children), and to enjoy social activities (57% of adults, 51% of children). Most patients (79%) reported worsening asthma symptoms when AR symptoms flared up. Many (56%) avoided the outdoors during the allergy season because of worsening asthma symptoms. Many (60%) indicated difficulty in effectively treating both conditions, and 72% were concerned about using excessive medication. In general, respondents from the Asia-Pacific region reported more disruption of activities caused by symptoms and more concerns and difficulties with medications than did those from Europe. Differences between the two regions in medication use included more common use of inhaled corticosteroids in Europe and more common use of Chinese herbal remedies in the Asia-Pacific region. CONCLUSION: Results of this survey suggest that comorbid asthma and AR substantially impact patient well-being and that the worsening of AR symptoms in patients with asthma can be associated with worsening asthma symptoms. These findings underscore the need for physicians who treat patients with asthma to evaluate treatment options for improving symptoms of both AR and asthma when present concomitantly. BioMed Central 2006-11-30 /pmc/articles/PMC1698496/ /pubmed/17140421 http://dx.doi.org/10.1186/1471-2466-6-S1-S3 Text en Copyright © 2006 Valovirta and Pawankar; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Valovirta, Erkka
Pawankar, Ruby
Survey on the impact of comorbid allergic rhinitis in patients with asthma
title Survey on the impact of comorbid allergic rhinitis in patients with asthma
title_full Survey on the impact of comorbid allergic rhinitis in patients with asthma
title_fullStr Survey on the impact of comorbid allergic rhinitis in patients with asthma
title_full_unstemmed Survey on the impact of comorbid allergic rhinitis in patients with asthma
title_short Survey on the impact of comorbid allergic rhinitis in patients with asthma
title_sort survey on the impact of comorbid allergic rhinitis in patients with asthma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698496/
https://www.ncbi.nlm.nih.gov/pubmed/17140421
http://dx.doi.org/10.1186/1471-2466-6-S1-S3
work_keys_str_mv AT valovirtaerkka surveyontheimpactofcomorbidallergicrhinitisinpatientswithasthma
AT pawankarruby surveyontheimpactofcomorbidallergicrhinitisinpatientswithasthma